This document provides an industry report on the Indian healthcare sector from October 2014. It includes sections on pharmaceuticals, industry statistics, product scans of x-ray machines and generic drugs, company and industry news, mergers and acquisitions, a company profile of Dr. Reddy's Laboratories, and upcoming events. Key highlights are the expected growth of the Indian pharmaceutical market to $55 billion by 2020, dominance of generic drugs, prevalence of counterfeit drugs, and focus on chronic disease segments and biologics.
Industry Monitor - Indian Healthcare Sector October 2014 (2)
1. Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Gyan Research and Analytics (Gyan). While
reasonable care has been taken in its preparation, Gyan makes no representation or warranty, express or implied, as to the accuracy, timeliness or
completeness of any such information. The information contained herein may be changed without notice. All information should be considered solely as
statements of opinion and Gyan will not be liable for any loss incurred by users from any use of the publication or contents.
Industry Monitor – Indian Healthcare
October 2014